Henry Schein names Frederick Lowery as new CEO

Henry Schein Inc. (NASDAQ: HSIC) announced Frederick M. Lowery will become chief executive officer effective March 2, 2026, succeeding Stanley M. Bergman who will step down after 35 years and continue as chairman of the board.

Lowery brings more than 20 years of healthcare distribution experience to the healthcare solutions provider. He most recently served as executive vice president and president of Laboratory Products and BioProduction at Thermo Fisher Scientific (NYSE: TMO), where he led the Fisher Scientific distribution channel.

Prior to Thermo Fisher, Lowery held leadership positions at Maytag Corporation and General Motors. He holds a master's degree in manufacturing management from Kettering University and a bachelor's degree in mechanical engineering from Tennessee Technological University.

"I am honored to join Henry Schein at such a pivotal moment," Lowery said in a statement. "I look forward to working with Team Schein to build on the strong foundation established by Stan while accelerating value creation."

Bergman praised the appointment, stating that Lowery "understands the critical role we play in supporting dental and medical practitioners, and he is exceptionally well equipped to lead Henry Schein into its next phase of growth."

Phil Laskawy, lead director and chair of the nominating and governance committee, said the board conducted a comprehensive search process and expressed confidence in Lowery's ability to lead the company forward.

Henry Schein provides healthcare solutions to office-based dental and medical professionals globally. The company reported sales of $12.7 billion in 2024 and operates through a network serving more than 1 million customers worldwide.

The information is based on a company press release.

You May Also Be Interested In